ResearcherTianjin University of Traditional Chinese MedicineNo recent work listed

Xuanming Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1413-3966; OpenAlex author ID A5033528168. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2022: 2 papers

Papers 2

Isobavachalcone Activates Antitumor Immunity on Orthotopic Pancreatic Cancer Model: A Screening and Validation First author DOI 10.21203/rs.3.rs-1491024/v2 ↗
Isobavachalcone Activates Antitumor Immunity on Orthotopic Pancreatic Cancer Model: A Screening and Validation. Co-author DOI 10.3389/fphar.2022.919035 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hongbo Zhang · 2 shared papers, 2022 · strength 0.30
- Paper Isobavachalcone Activates Antitumor Immunity on Orthotopic Pancreatic Cancer Model: A Screening and Validation DOI 10.21203/rs.3.rs-1491024/v2 ↗
- Paper Isobavachalcone Activates Antitumor Immunity on Orthotopic Pancreatic Cancer Model: A Screening and Validation. DOI 10.3389/fphar.2022.919035 ↗
Yan Wang · 2 shared papers, 2022 · strength 0.30
- Paper Isobavachalcone Activates Antitumor Immunity on Orthotopic Pancreatic Cancer Model: A Screening and Validation DOI 10.21203/rs.3.rs-1491024/v2 ↗
- Paper Isobavachalcone Activates Antitumor Immunity on Orthotopic Pancreatic Cancer Model: A Screening and Validation. DOI 10.3389/fphar.2022.919035 ↗
Lei Yang · 1 shared paper, 2022 · strength 0.15
- Paper Isobavachalcone Activates Antitumor Immunity on Orthotopic Pancreatic Cancer Model: A Screening and Validation. DOI 10.3389/fphar.2022.919035 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.